HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.

7th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 19-21, 2026 | Boston, Massachusetts, USA

Neurocognitive Testing in Addiction Disorders

Neurocognitive Testing in Addiction Disorders

Neurocognitive testing evaluates cognitive deficits commonly associated with addiction, such as impaired memory, attention, and executive functioning. Substance use often damages brain regions like the prefrontal cortex and hippocampus, leading to difficulties in decision-making, impulse control, and learning. Standardized tests, such as the Wisconsin Card Sorting Test and Stroop Test, help identify these impairments and guide personalized treatment plans. Neurocognitive assessments also aid in tracking recovery progress and predicting relapse risk. Integrating these evaluations into addiction care provides a comprehensive understanding of how substance use impacts brain function and highlights areas requiring cognitive rehabilitation.

Tags

Submit your abstract Today

Watsapp